LifeWave X39 Science and Research: Summary of Published Studies

LifeWave X39 Science & Research

About This Page: This section compiles published research and pilot studies exploring the science behind the LifeWave X39 patch. Each summary links directly to the original study or report for those who wish to review the data in detail.

Overview

The LifeWave X39 patch has been studied for its potential to support the body’s natural healing processes through phototherapy and activation of the copper peptide GHK-Cu. Below are summaries of published and preliminary studies exploring its effects on metabolism, brain activity, biofield balance, and regenerative mechanisms.


2021 - X39 GHK-Cu Study: Double-Blind Testing of the LifeWave X39 Patch to Determine GHK-Cu Production Levels

A double-blind, randomized controlled study published in the Internal Medicine Research – Open Journal evaluated whether the X39 patch increases levels of the copper peptide GHK-Cu in human subjects. Results showed a statistically significant increase in copper-peptide concentrations in the blood of subjects who had worn the X39 patches for one week compared to placebo.

View Study (PDF)


2021 - X39 Metabolism & Amino Acid Study: Phototherapy-Induced Metabolism Change Produced by the LifeWave X39 Non-Transdermal Patch

A double-blind randomized controlled study published in the International Journal of Research Studies in Medical and Health Sciences examined short-term metabolic effects of the X39 patch. Participants who wore the patch for seven days showed a significant increase in eight amino acids associated with energy, sleep quality, and short-term memory. Researchers concluded that X39 may help improve metabolic balance and vitality through phototherapy stimulation.

View Study (PDF)


2020 - X39 Amino Acid Pilot Study: Light-Triggered Changes in Metabolism & Physiology

A pilot, open-label study published in the International Journal of Healing and Caring examined metabolic and physiological changes after seven days of X39 use. Fifteen adults (ages 40–65) wore the patch daily for 8–12 hours. Measurements included amino acid profiles, stress hormones (cortisol, DHEAS), heart rate variability, blood pressure, and sleep and memory surveys. Researchers observed significant changes in multiple amino acids, improved sleep and memory, and enhanced vitality. Because this was a small, non-placebo pilot, findings are exploratory and warrant further study.

View Study (PDF)


2019 - X39 Brain Study: Effect of LifeWave X39 Patches on Brain as Seen with P3 Brain Mapping

A pilot study conducted by PSY-TEK Labs evaluated brainwave activity after participants wore the X39 patch for three weeks. Researchers observed notable changes in scalp topographic maps, including increased P300 amplitude and improved brain coherence across multiple channels, suggesting possible effects on neural synchronization and cognitive processing.

View Study (PDF)


2021 - X39 Biofield Study: Experimental Study of LifeWave, Inc. X-39 Patches

A pilot biofield investigation conducted by The Center for Biofield Sciences examined 45 participants over six weeks using Biofield Viewer, Bio-Well (EPI/GDV), and Multiscan Pro analysis. Results indicated increased overall biofield energy (p<0.0001), improved left-right organ balance (p<0.05), and enhanced energetic symmetry in participants using the X39 patch. Control group data showed minimal change. Authors noted these findings as preliminary and recommended larger double-blind trials.

View Study (PDF)


2018 - X39 Peptide Study: Regenerative and Protective Actions of the GHK-Cu Peptide in Light of New Gene Data

Published in the International Journal of Molecular Sciences (Pickart et al.), this peer-reviewed paper explores how GHK-Cu affects thousands of human genes linked to collagen and elastin production, tissue repair, anti-inflammatory activity, DNA repair, and cellular cleansing. The study notes that GHK-Cu "stimulates blood vessel and nerve outgrowth, increases collagen and elastin, improves tissue repair, and shows anti-inflammatory, lung-protective, anti-anxiety, anti-pain, and DNA-repair actions." While not an X39 clinical trial, it provides the scientific foundation for the technology’s proposed mechanism of action.

View Study (PDF)


Scientific Perspective

These studies collectively suggest potential biological activity from GHK-Cu activation and phototherapy using the LifeWave X39 patch. Preliminary results indicate possible benefits in metabolic balance, biofield energy, sleep, and regenerative processes. However, most studies are small-scale, short-term, or exploratory. Larger, independent, double-blind clinical trials are needed to validate these findings and clarify the mechanisms involved.

Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health-related decisions.